Molecular evidence of Pneumocystis transmission in pediatric transplant unit

Britta Höcker1, Constanze Wendt, Aimable Nahimana

  • 1University Children's Hospital, Im Neuenheimer Feld 150, 69120 Heidelberg, Germany. Britta_Hoecker@med.uni-heidelberg.de

Insights

An outbreak of Pneumocystis jirovecii pneumonia in pediatric kidney transplant patients suggests human-to-human spread. Molecular typing confirmed shared strains among three patients, indicating infection transmission within the unit.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection.
  • Renal transplant recipients are at high risk for infections, including PCP.
  • Understanding transmission dynamics is crucial for infection control in immunocompromised populations.

Purpose of the Study:

  • To investigate an outbreak of PCP in a pediatric renal transplant unit.
  • To determine the transmission route of Pneumocystis jirovecii during the outbreak.
  • To identify the source and spread of infection within the unit.

Main Methods:

  • Retrospective case review of patients with PCP in the pediatric renal transplant unit.
  • Molecular typing using single-strand conformation polymorphism (SSCP) to analyze Pneumocystis jirovecii strains.
  • Epidemiological investigation to identify potential transmission links.

Main Results:

  • An outbreak of PCP occurred in the pediatric renal transplant unit.
  • Molecular typing identified two common strains of Pneumocystis in three affected patients.
  • An infant with mitochondriopathy was identified as the likely index case.

Conclusions:

  • The findings strongly suggest patient-to-patient transmission of Pneumocystis jirovecii within the unit.
  • Interhuman spread is a significant concern in pediatric renal transplant settings.
  • Implementing enhanced infection control measures is vital to prevent future outbreaks.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...